Menter A - Search Results

1

Menter A, Arenberger P, Balser S, Beissert S, Cauthen A, Czeloth N, Soung J, Jazayeri S, Weisenseel P, Jayadeva G. Menter A, et al. Expert Opin Biol Ther. 2021 Jan;21(1):87-96. doi: 10.1080/14712598.2021.1851362. Epub 2020 Dec 29. Expert Opin Biol Ther. 2021. PMID: 33317345 Clinical Trial.

2

Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.

Cather JC, Cather JC, Menter A. Cather JC, et al. Among authors: menter a. Expert Opin Biol Ther. 2003 Apr;3(2):361-70. doi: 10.1517/14712598.3.2.361. Expert Opin Biol Ther. 2003. PMID: 12662148 Review.

3

Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis.

Menter A, Kosinski M, Bresnahan BW, Papp KA, Ware JE Jr. Menter A, et al. J Drugs Dermatol. 2004 Jan-Feb;3(1):27-38. J Drugs Dermatol. 2004. PMID: 14964744 Clinical Trial.

4

Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.

Menter A, Gordon K, Carey W, Hamilton T, Glazer S, Caro I, Li N, Gulliver W. Menter A, et al. Arch Dermatol. 2005 Jan;141(1):31-8. doi: 10.1001/archderm.141.1.31. Arch Dermatol. 2005. PMID: 15655139 Clinical Trial.

5

Efalizumab: continuous therapy for chronic psoriasis.

Cather JC, Menter A. Cather JC, et al. Among authors: menter a. Expert Opin Biol Ther. 2005 Mar;5(3):393-403. doi: 10.1517/14712598.5.3.393. Expert Opin Biol Ther. 2005. PMID: 15833076 Review.

6

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis.

Menter A, Cather JC, Baker D, Farber HF, Lebwohl M, Darif M. Menter A, et al. J Am Acad Dermatol. 2006 Jan;54(1):61-3. doi: 10.1016/j.jaad.2005.10.006. J Am Acad Dermatol. 2006. PMID: 16384756

7

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.

Menter A, Feldman SR, Weinstein GD, Papp K, Evans R, Guzzo C, Li S, Dooley LT, Arnold C, Gottlieb AB. Menter A, et al. J Am Acad Dermatol. 2007 Jan;56(1):31.e1-15. doi: 10.1016/j.jaad.2006.07.017. Epub 2006 Sep 6. J Am Acad Dermatol. 2007. PMID: 17097378 Clinical Trial.

8

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

Menter A, Tyring SK, Gordon K, Kimball AB, Leonardi CL, Langley RG, Strober BE, Kaul M, Gu Y, Okun M, Papp K. Menter A, et al. J Am Acad Dermatol. 2008 Jan;58(1):106-15. doi: 10.1016/j.jaad.2007.09.010. Epub 2007 Oct 23. J Am Acad Dermatol. 2008. PMID: 17936411 Clinical Trial.

9

Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasis.

Perlmutter A, Cather J, Franks B, Jaracz E, Menter A. Perlmutter A, et al. Among authors: menter a. J Am Acad Dermatol. 2008 Jan;58(1):116-24. doi: 10.1016/j.jaad.2007.09.030. Epub 2007 Nov 12. J Am Acad Dermatol. 2008. PMID: 17997502

10

Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials.

Brimhall AK, King LN, Licciardone JC, Jacobe H, Menter A. Brimhall AK, et al. Among authors: menter a. Br J Dermatol. 2008 Aug;159(2):274-85. doi: 10.1111/j.1365-2133.2008.08673.x. Epub 2008 Jun 10. Br J Dermatol. 2008. PMID: 18547300 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page